学科主题 | 精神卫生 |
Early Cannabis Use and Estimated Risk of Later Onset of Depression Spells: Epidemiologic Evidence From the Population-based World Health Organization World Mental Health Survey Initiative | |
de Graaf, Ron1; Radovanovic, Mirjana2,3; van Laar, Margriet1; Fairman, Brian2; Degenhardt, Louisa4; Aguilar-Gaxiola, Sergio5; Bruffaerts, Ronny6; de Girolamo, Giovanni7; Fayyad, John8; Gureje, Oye9; Maria Haro, Josep10; Huang, Yueqin11; Kostychenko, Stanislav12; Lepine, Jean-Pierre13; Matschinger, Herbert14; Medina Mora, Maria Elena15; Neumark, Yehuda16; Ormel, Johan17,18; Posada-Villa, Jose19; Stein, Dan J.20; Tachimori, Hisateru21; Wells, J. Elisabeth22; Anthony, James C.2 | |
关键词 | Cannabis Depression Mental Health World Health |
刊名 | AMERICAN JOURNAL OF EPIDEMIOLOGY
![]() |
2010-07-15 | |
DOI | 10.1093/aje/kwq096 |
卷 | 172期:2页:149-159 |
收录类别 | SCI ; SSCI |
文章类型 | Article |
WOS标题词 | Science & Technology |
类目[WOS] | Public, Environmental & Occupational Health |
资助者 | US National Institute of Mental Health ; John D. and Catherine T. MacArthur Foundation ; Pfizer Foundation ; US Public Health Service ; Fogarty International Center ; Pan American Health Organization ; Eli Lilly & ; Company Foundation ; Ortho-McNeil Pharmaceutical, Inc. ; GlaxoSmithKline ; Bristol-Myers Squibb ; Shire ; Ministry of Social Protection of Colombia ; European Commission ; Piedmont Region (Italy) ; Fondo de Investigacion Sanitaria ; Instituto de Salud Carlos III (Spain) ; Ministerio de Ciencia y Tecnologia (Spain) ; Departament de Salut ; Generalitat de Catalunya ; Israeli Ministry of Health ; Israeli National Institute for Health Policy and Health Services Research ; National Insurance Institute of Israel ; Japanese Ministry of Health, Labour and Welfare ; Lebanese Ministry of Public Health ; World Health Organization (Lebanon) ; Fogarty International ; Janssen Cilag ; Eli Lilly ; Roche ; Novartis ; National Institute of Psychiatry Ramon de la Fuente ; National Council on Science and Technology ; New Zealand Ministry of Health ; Alcohol Advisory Council ; Health Research Council ; World Health Organization (Geneva and Nigeria) ; Federal Ministry of Health, Abuja, Nigeria ; US National Institute of Mental Health (NIMH) ; US National Institute on Drug Abuse (NIDA) ; South African Department of Health ; University of Michigan ; NIMH ; NIDA ; Substance Abuse and Mental Health Services Administration (US Department of Health and Human Services) ; Robert Wood Johnson Foundation ; John W. Alden Trust ; National Institutes of Health (NIH)/National Institute on Drug Abuse (NIDA) ; Michigan State University ; AstraZeneca ; Johnson Johnson ; Lundbeck ; Orion ; Pfizer ; Pharmacia ; Servier ; Solvay ; Sumitomo ; Tikvah ; Wyeth ; US National Institute of Mental Health ; John D. and Catherine T. MacArthur Foundation ; Pfizer Foundation ; US Public Health Service ; Fogarty International Center ; Pan American Health Organization ; Eli Lilly & ; Company Foundation ; Ortho-McNeil Pharmaceutical, Inc. ; GlaxoSmithKline ; Bristol-Myers Squibb ; Shire ; Ministry of Social Protection of Colombia ; European Commission ; Piedmont Region (Italy) ; Fondo de Investigacion Sanitaria ; Instituto de Salud Carlos III (Spain) ; Ministerio de Ciencia y Tecnologia (Spain) ; Departament de Salut ; Generalitat de Catalunya ; Israeli Ministry of Health ; Israeli National Institute for Health Policy and Health Services Research ; National Insurance Institute of Israel ; Japanese Ministry of Health, Labour and Welfare ; Lebanese Ministry of Public Health ; World Health Organization (Lebanon) ; Fogarty International ; Janssen Cilag ; Eli Lilly ; Roche ; Novartis ; National Institute of Psychiatry Ramon de la Fuente ; National Council on Science and Technology ; New Zealand Ministry of Health ; Alcohol Advisory Council ; Health Research Council ; World Health Organization (Geneva and Nigeria) ; Federal Ministry of Health, Abuja, Nigeria ; US National Institute of Mental Health (NIMH) ; US National Institute on Drug Abuse (NIDA) ; South African Department of Health ; University of Michigan ; NIMH ; NIDA ; Substance Abuse and Mental Health Services Administration (US Department of Health and Human Services) ; Robert Wood Johnson Foundation ; John W. Alden Trust ; National Institutes of Health (NIH)/National Institute on Drug Abuse (NIDA) ; Michigan State University ; AstraZeneca ; Johnson Johnson ; Lundbeck ; Orion ; Pfizer ; Pharmacia ; Servier ; Solvay ; Sumitomo ; Tikvah ; Wyeth |
研究领域[WOS] | Public, Environmental & Occupational Health |
关键词[WOS] | NATIONAL COMORBIDITY SURVEY ; SUBSTANCE USE ; DRUG-USE ; ANXIETY DISORDERS ; PSYCHOSOCIAL ADJUSTMENT ; YOUNG ADULTHOOD ; MARIJUANA USE ; TOBACCO USE ; ALCOHOL ; ASSOCIATION |
英文摘要 | Early-onset cannabis use is widespread in many countries and might cause later onset of depression. Sound epidemiologic data across countries are missing. The authors estimated the suspected causal association that links early-onset (age < 17 years) cannabis use with later-onset (age >= 17 years) risk of a depression spell, using data on 85,088 subjects from 17 countries participating in the population-based World Health Organization World Mental Health Survey Initiative (2001-2005). In all surveys, multistage household probability samples were evaluated with a fully structured diagnostic interview for assessment of psychiatric conditions. The association between early-onset cannabis use and later risk of a depression spell was studied using conditional logistic regression with local area matching of cases and controls, controlling for sex, age, tobacco use, and other mental health problems. The overall association was modest (controlled for sex and age, risk ratio = 1.5, 95% confidence interval: 1.4, 1.7), was statistically robust in 5 countries, and showed no sex difference. The association did not change appreciably with statistical adjustment for mental health problems, except for childhood conduct problems, which reduced the association to nonsignificance. This study did not allow differentiation of levels of cannabis use; this issue deserves consideration in future research. |
语种 | 英语 |
所属项目编号 | R01MH070884 ; R13-MH066849 ; R01-MH069864 ; R01 DA016558 ; FIRCA R03-TW006481 ; QLG5-1999-01042 ; SANCO 2004123 ; FIS 00/0028 ; CIBER CB06/02/0046 ; RETICS RD06/0011 REM-TAP ; SAF 2000-158-CE ; H13-SHOGAI-023 ; H14-TOKUBETSU-026 ; H16-KOKORO-013 ; INPRFMDIES 4280 ; G30544-H ; R01-MH059575 ; RO1-MH61905 ; U01-MH60220 ; 044708 ; DA016558 ; DA015799 ; DA021129 |
资助者 | US National Institute of Mental Health ; John D. and Catherine T. MacArthur Foundation ; Pfizer Foundation ; US Public Health Service ; Fogarty International Center ; Pan American Health Organization ; Eli Lilly & ; Company Foundation ; Ortho-McNeil Pharmaceutical, Inc. ; GlaxoSmithKline ; Bristol-Myers Squibb ; Shire ; Ministry of Social Protection of Colombia ; European Commission ; Piedmont Region (Italy) ; Fondo de Investigacion Sanitaria ; Instituto de Salud Carlos III (Spain) ; Ministerio de Ciencia y Tecnologia (Spain) ; Departament de Salut ; Generalitat de Catalunya ; Israeli Ministry of Health ; Israeli National Institute for Health Policy and Health Services Research ; National Insurance Institute of Israel ; Japanese Ministry of Health, Labour and Welfare ; Lebanese Ministry of Public Health ; World Health Organization (Lebanon) ; Fogarty International ; Janssen Cilag ; Eli Lilly ; Roche ; Novartis ; National Institute of Psychiatry Ramon de la Fuente ; National Council on Science and Technology ; New Zealand Ministry of Health ; Alcohol Advisory Council ; Health Research Council ; World Health Organization (Geneva and Nigeria) ; Federal Ministry of Health, Abuja, Nigeria ; US National Institute of Mental Health (NIMH) ; US National Institute on Drug Abuse (NIDA) ; South African Department of Health ; University of Michigan ; NIMH ; NIDA ; Substance Abuse and Mental Health Services Administration (US Department of Health and Human Services) ; Robert Wood Johnson Foundation ; John W. Alden Trust ; National Institutes of Health (NIH)/National Institute on Drug Abuse (NIDA) ; Michigan State University ; AstraZeneca ; Johnson Johnson ; Lundbeck ; Orion ; Pfizer ; Pharmacia ; Servier ; Solvay ; Sumitomo ; Tikvah ; Wyeth ; US National Institute of Mental Health ; John D. and Catherine T. MacArthur Foundation ; Pfizer Foundation ; US Public Health Service ; Fogarty International Center ; Pan American Health Organization ; Eli Lilly & ; Company Foundation ; Ortho-McNeil Pharmaceutical, Inc. ; GlaxoSmithKline ; Bristol-Myers Squibb ; Shire ; Ministry of Social Protection of Colombia ; European Commission ; Piedmont Region (Italy) ; Fondo de Investigacion Sanitaria ; Instituto de Salud Carlos III (Spain) ; Ministerio de Ciencia y Tecnologia (Spain) ; Departament de Salut ; Generalitat de Catalunya ; Israeli Ministry of Health ; Israeli National Institute for Health Policy and Health Services Research ; National Insurance Institute of Israel ; Japanese Ministry of Health, Labour and Welfare ; Lebanese Ministry of Public Health ; World Health Organization (Lebanon) ; Fogarty International ; Janssen Cilag ; Eli Lilly ; Roche ; Novartis ; National Institute of Psychiatry Ramon de la Fuente ; National Council on Science and Technology ; New Zealand Ministry of Health ; Alcohol Advisory Council ; Health Research Council ; World Health Organization (Geneva and Nigeria) ; Federal Ministry of Health, Abuja, Nigeria ; US National Institute of Mental Health (NIMH) ; US National Institute on Drug Abuse (NIDA) ; South African Department of Health ; University of Michigan ; NIMH ; NIDA ; Substance Abuse and Mental Health Services Administration (US Department of Health and Human Services) ; Robert Wood Johnson Foundation ; John W. Alden Trust ; National Institutes of Health (NIH)/National Institute on Drug Abuse (NIDA) ; Michigan State University ; AstraZeneca ; Johnson Johnson ; Lundbeck ; Orion ; Pfizer ; Pharmacia ; Servier ; Solvay ; Sumitomo ; Tikvah ; Wyeth |
WOS记录号 | WOS:000280263900005 |
Citation statistics | |
文献类型 | 期刊论文 |
条目标识符 | http://ir.bjmu.edu.cn/handle/400002259/54062 |
Collection | 北京大学精神卫生研究所 |
作者单位 | 1.Peking Univ, Inst Mental Hlth, Beijing 100871, Peoples R China 2.Ukrainian Psychiat Assoc, Kiev, Ukraine 3.Univ Leipzig, Dept Psychiat, Leipzig, Germany 4.Natl Inst Psychiat, Mexico City, DF, Mexico 5.Netherlands Inst Mental Hlth & Addict, Dept Epidemiol, NL-3521 VS Utrecht, Netherlands 6.Michigan State Univ, Coll Human Med, Dept Epidemiol, E Lansing, MI 48824 USA 7.Univ Psychiat Hosp, Ljubljana, Slovenia 8.Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW, Australia 9.Univ Calif Davis, Ctr Reducing Hlth Dispar, Sch Med, Davis, CA 95616 USA 10.Univ Hosp Gasthuisberg, B-3000 Louvain, Belgium 11.Ctr S Giovanni di Dio Fatebenefratelli, Brescia, Italy 12.Univ Coll Ibadan Hosp, Ibadan, Nigeria 13.CIBER Salud Mental, Fundacio St Joan de Deu, Barcelona, Spain 14.Balamand Univ, Inst Dev Res Advocacy & Appl Care, Dept Psychiat & Clin Psychol, St George Hosp Univ Med Ctr, Beirut, Lebanon 15.Univ Paris Diderot, Hop Lariboisiere Fernand Widal, CNRS UMR 7157, AP HP,INSERM,U705, Paris, France 16.Hebrew Univ Jerusalem, Sch Publ Hlth & Community Med, Hadassah, Israel 17.Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, NL-9713 AV Groningen, Netherlands 18.Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol & Bioinformat, NL-9713 AV Groningen, Netherlands 19.Pontificia Univ Javeriana, Ctr Med Sabana, Bogota, Colombia 20.Univ Cape Town, Dept Psychiat & Mental Hlth, Fac Hlth Sci, ZA-7925 Cape Town, South Africa 21.Natl Ctr Neurol & Psychiat, Natl Inst Mental Hlth, Tokyo, Japan 22.Univ Otago, Dept Publ Hlth & Gen Practice, Sch Med & Hlth Sci, Christchurch, New Zealand |
Recommended Citation GB/T 7714 | de Graaf, Ron,Radovanovic, Mirjana,van Laar, Margriet,et al. Early Cannabis Use and Estimated Risk of Later Onset of Depression Spells: Epidemiologic Evidence From the Population-based World Health Organization World Mental Health Survey Initiative[J]. AMERICAN JOURNAL OF EPIDEMIOLOGY,2010,172(2):149-159. |
APA | de Graaf, Ron.,Radovanovic, Mirjana.,van Laar, Margriet.,Fairman, Brian.,Degenhardt, Louisa.,...&Anthony, James C..(2010).Early Cannabis Use and Estimated Risk of Later Onset of Depression Spells: Epidemiologic Evidence From the Population-based World Health Organization World Mental Health Survey Initiative.AMERICAN JOURNAL OF EPIDEMIOLOGY,172(2),149-159. |
MLA | de Graaf, Ron,et al."Early Cannabis Use and Estimated Risk of Later Onset of Depression Spells: Epidemiologic Evidence From the Population-based World Health Organization World Mental Health Survey Initiative".AMERICAN JOURNAL OF EPIDEMIOLOGY 172.2(2010):149-159. |
Files in This Item: | There are no files associated with this item. |
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.
Edit Comment